FindTrial
Sign In

Drug concentration comparison in peripheral nerve block for foot surgeries

Comparison of Ropivacaine 0.5 percent and Ropivacaine 0.75 percent in proximal popliteal sciatic nerve block for foot surgeries - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085778
Enrollment
50
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S908- Other superficial injuries of foot

Interventions

Intervention1: ROPIVACAINE 0.75 PERCENT: THE OTHER GROUP IN THIS STUDY WILL RECEIVE ROPIVACAINE 0.75% FOR POPLITEAL SCIATIC BLOCK AND WILL BE MONITERED FOR 24 HOURS FOR ANALGESIA POST OPERATIVELY Cont

Sponsors

D Y PATIL MEDICAL COLLEGEHOSPITAL AND RESEARCH INSTITUTE KOLHAPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)ASA grade I , II , III and IV 2)Posted for elective foot surgeries

Exclusion criteria

Exclusion criteria: 1)Patient not giving consent for the procedure 2)local skin infections 3)suspected coagulopathy or bleeding diathesis 4)allergy to local anesthetics and study drug 5)patient who cannot be given lateral position 6)BMI >30 kg/m2 -patients requiring midthigh tourniquet for the surgery 7)uncontrolled diabetes mellitus 8)patient with neurodeficit in lower limb 9)patient in whom there is no action or partial action of block even after20 minutes of giving the block

Design outcomes

Primary

MeasureTime frame
to study time of onset of action and duration of analgesia with ropivacaine 0.5% v/s ropivacaine 0.75%Timepoint: 20 minutes , 4 hours, 8 hours,12 hours,16 hours,20 hours, 24 hours—

Secondary

MeasureTime frame
to study total post operative analgesia requirementTimepoint: zero minute,4hr,8,12,16,20,24 hr—

Countries

India

Contacts

Public ContactDR SHIVANI ARUNKUMAR SOMANI

D Y PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, KOLHAPUR

rashmeechavan@rediffmail.com9823243848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026